Synopsis
The global Whole genome amplification market report provides analysis and insights on Whole genome amplification kits and consumables. Commercially available Whole genome amplification kits are based on Single cell WGA kits, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and others.
The global Whole Genome Amplification market size is expected to reach US$ 796 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of Whole Genome Amplification in various end use industries. The expanding demands from the Drug Discovery & Development, Disease Diagnosis, Agriculture & Veterinary and Research, are propelling Whole Genome Amplification market. Single Cell WGA Kit, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Complete WGA Kit segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Whole Genome Amplification market, driven by demand from China, the second largest economy with some signs of stabilising, the Whole Genome Amplification market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Whole Genome Amplification, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Whole Genome Amplification market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Whole Genome Amplification market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Whole Genome Amplification sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Whole Genome Amplification covered in this report include Sigma-Aldrich, QIAGEN NV, GE Healthcare and LGC Group, etc.
The global Whole Genome Amplification market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sigma-Aldrich
QIAGEN NV
GE Healthcare
LGC Group
Global Whole Genome Amplification market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Whole Genome Amplification market, Segment by Type:
Single Cell WGA Kit
Complete WGA Kit
WGA Reamplification Kit
WGA & Chip DNA Kit
Others
Global Whole Genome Amplification market, by Application
Drug Discovery & Development
Disease Diagnosis
Agriculture & Veterinary
Research
Forensics
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Whole Genome Amplification companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Whole Genome Amplification
1.1 Whole Genome Amplification Market Overview
1.1.1 Whole Genome Amplification Product Scope
1.1.2 Whole Genome Amplification Market Status and Outlook
1.2 Global Whole Genome Amplification Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Whole Genome Amplification Market Size by Region (2018-2029)
1.4 Global Whole Genome Amplification Historic Market Size by Region (2018-2023)
1.5 Global Whole Genome Amplification Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Whole Genome Amplification Market Size (2018-2029)
1.6.1 North America Whole Genome Amplification Market Size (2018-2029)
1.6.2 Europe Whole Genome Amplification Market Size (2018-2029)
1.6.3 Asia-Pacific Whole Genome Amplification Market Size (2018-2029)
1.6.4 Latin America Whole Genome Amplification Market Size (2018-2029)
1.6.5 Middle East & Africa Whole Genome Amplification Market Size (2018-2029)
2 Whole Genome Amplification Market by Type
2.1 Introduction
2.1.1 Single Cell WGA Kit
2.1.2 Complete WGA Kit
2.1.3 WGA Reamplification Kit
2.1.4 WGA & Chip DNA Kit
2.1.5 Others
2.2 Global Whole Genome Amplification Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Whole Genome Amplification Historic Market Size by Type (2018-2023)
2.2.2 Global Whole Genome Amplification Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Whole Genome Amplification Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Whole Genome Amplification Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Whole Genome Amplification Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Whole Genome Amplification Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Whole Genome Amplification Revenue Breakdown by Type (2018-2029)
3 Whole Genome Amplification Market Overview by Application
3.1 Introduction
3.1.1 Drug Discovery & Development
3.1.2 Disease Diagnosis
3.1.3 Agriculture & Veterinary
3.1.4 Research
3.1.5 Forensics
3.1.6 Others
3.2 Global Whole Genome Amplification Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Whole Genome Amplification Historic Market Size by Application (2018-2023)
3.2.2 Global Whole Genome Amplification Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Whole Genome Amplification Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Whole Genome Amplification Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Whole Genome Amplification Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Whole Genome Amplification Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Whole Genome Amplification Revenue Breakdown by Application (2018-2029)
4 Whole Genome Amplification Competition Analysis by Players
4.1 Global Whole Genome Amplification Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Whole Genome Amplification as of 2022)
4.3 Date of Key Players Enter into Whole Genome Amplification Market
4.4 Global Top Players Whole Genome Amplification Headquarters and Area Served
4.5 Key Players Whole Genome Amplification Product Solution and Service
4.6 Competitive Status
4.6.1 Whole Genome Amplification Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sigma-Aldrich
5.1.1 Sigma-Aldrich Profile
5.1.2 Sigma-Aldrich Main Business
5.1.3 Sigma-Aldrich Whole Genome Amplification Products, Services and Solutions
5.1.4 Sigma-Aldrich Whole Genome Amplification Revenue (US$ Million) & (2018-2023)
5.1.5 Sigma-Aldrich Recent Developments
5.2 QIAGEN NV
5.2.1 QIAGEN NV Profile
5.2.2 QIAGEN NV Main Business
5.2.3 QIAGEN NV Whole Genome Amplification Products, Services and Solutions
5.2.4 QIAGEN NV Whole Genome Amplification Revenue (US$ Million) & (2018-2023)
5.2.5 QIAGEN NV Recent Developments
5.3 GE Healthcare
5.3.1 GE Healthcare Profile
5.3.2 GE Healthcare Main Business
5.3.3 GE Healthcare Whole Genome Amplification Products, Services and Solutions
5.3.4 GE Healthcare Whole Genome Amplification Revenue (US$ Million) & (2018-2023)
5.3.5 LGC Group Recent Developments
5.4 LGC Group
5.4.1 LGC Group Profile
5.4.2 LGC Group Main Business
5.4.3 LGC Group Whole Genome Amplification Products, Services and Solutions
5.4.4 LGC Group Whole Genome Amplification Revenue (US$ Million) & (2018-2023)
5.4.5 LGC Group Recent Developments
6 North America
6.1 North America Whole Genome Amplification Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Whole Genome Amplification Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Whole Genome Amplification Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Whole Genome Amplification Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Whole Genome Amplification Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Whole Genome Amplification Market Dynamics
11.1 Whole Genome Amplification Industry Trends
11.2 Whole Genome Amplification Market Drivers
11.3 Whole Genome Amplification Market Challenges
11.4 Whole Genome Amplification Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List